Acute-On-Chronic Liver Failure in Zagazig University Hospitals
ACLF
ACLF in Zagazig University Hospitals
1 other identifier
observational
300
1 country
1
Brief Summary
Rationale: To identify the prevalence of Acute-on-chronic liver failure in Zagazig University Hospitals. The question of the research: How much the prevalence of Acute-on-chronic Liver Failure in Zagazig University Hospitals? The aim of the work: The aim of the study is to identify the presence of Acute-on-chronic Liver Failure in Zagazig University Hospitals Objectives: To estimate the prevalence of Acute-on-chronic Liver Failure in Zagazig University Hospitals. Subjects and Methods: I . Technical Design:
- Site of the study: Gastroenterology and Hepatology Unit- Zagazig University Hospitals
- Sample size: ''all patients admitted to Gastroenterology and Hepatology Unit with the criteria of ACLF according to EASL-AASLD from June 2017 to December 2017 were included in this study''. II . OPERATIONAL DESIGN:
- Type of the study: a prospective study.
- Full medical history - taking.
- Full clinical examination.
- Laboratory investigations including Routine laboratory investigation " CBC, Liver functions test, kidney functions test and prothrombin time " III. Administrative Design:
- Approvals obtained for performing the study from the official or governmental department.
- An ethical committee from the faculty of medicine and patients included in the study. Results: Collected data will be presented in tables and suitable graphs and analyzed according to standard statistical methods
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 7, 2017
CompletedFirst Posted
Study publicly available on registry
June 12, 2017
CompletedStudy Start
First participant enrolled
July 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 11, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 11, 2018
CompletedAugust 14, 2018
August 1, 2018
1.1 years
June 7, 2017
August 12, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
improvement of the patients score according to SOFA score (AASLD and EASL guidelines)
follow up of participants until the patients recover
24 weeks from first recruiting
Secondary Outcomes (1)
death of the patient
24 weeks from first recruiting
Eligibility Criteria
All patients admitted to Gastroenterology and Hepatology Unit with the criteria of ACLF according to EASL-AASLD will be included in this study.
You may qualify if:
- all patients admitted to Gastroenterology and Hepatology Unit with the criteria of ACLF according to EASL-AASLD will be included in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Salem Mohamed
Zagazig, Sharqia Province, 44519, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor of internal medicine, gastroenterology and hepatology unit
Study Record Dates
First Submitted
June 7, 2017
First Posted
June 12, 2017
Study Start
July 1, 2017
Primary Completion
August 11, 2018
Study Completion
August 11, 2018
Last Updated
August 14, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share